SCHEMBL6483863

SCHEMBL6483863

O=S(=O)(Nc1cccc(CCOCc2ccc(-c3ccc(Cl)cc3)cc2)c1)C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 2/20 0.47
PPARG P37231 1/20 0.47
KDM1A O60341 2/20 0.41
CA2 P00918 2/20 0.41
MAPT P10636 1/20 0.39
CYSLTR2 Q9NS75 1/20 0.38
CYSLTR1 Q9Y271 1/20 0.38
CYP3A4 P08684 3/20 0.37
CYP2D6 P10635 3/20 0.37
SLC6A2 P23975 3/20 0.37
SLC6A4 P31645 3/20 0.37
SLC6A3 Q01959 3/20 0.37
KCNH2 Q12809 1/20 0.37
PTGS1 P23219 2/20 0.36
PTGS2 P35354 2/20 0.36
CA1 P00915 1/20 0.36
CYP19A1 P11511 1/20 0.36
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HSD11B1 P28845 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6474092 0.94 PPARA (0.41) PPARAPPARGKDM1ACA2MAPT
SCHEMBL6482194 0.93 KDM1A (0.43) PPARAPPARGKDM1ACA2CYSLTR2
SCHEMBL6474008 0.91 CYP3A4 (0.45) PPARAPPARGKDM1ACA2CYSLTR2
SCHEMBL6479679 0.90 KDM1A (0.42) PPARAPPARGKDM1ACA2MAPT
SCHEMBL6482520 0.89 KIF11 (0.46) PPARAPPARGKDM1ACA2CYSLTR2
SCHEMBL6475686 0.89 PPARA (0.41) PPARAPPARGKDM1ACA2MAPT
SCHEMBL6474786 0.87 LTB4R (0.41) PPARAKDM1ACA2CYSLTR2CYSLTR1
SCHEMBL6473722 0.87 ADRB1 (0.39) PPARAPPARGKDM1ACA2MAPT
SCHEMBL6474487 0.85 PPARA (0.39) PPARAPPARGKDM1ACA2MAPT
SCHEMBL6480341 0.85 PPARA (0.39) PPARAPPARGKDM1ACA2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6930131-B2 Aryl substituted 3-ethoxy phenyl trifluoromethane sulfonamides for the treatment of non-insulin dependent diabetes mellitus (NIDDM) WYETH (US) 2005-08-16 US disclosed
US-20030203941-A1 Substituted phenyl compounds for the treatment of non-insulin dependent diabetes mellitus WYETH (US) 2003-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203941-A1 Substituted phenyl compounds for the treatment of non-insulin dependent diabetes mellitus GPR119, INSR, SLC5A1 PPARA 291/4885PPARG 256/4885KDM1A 1124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.